Effect of cisplatin on metastatic castration-resistant prostate cancer with BRCA2 mutation: A case report

Poly (ADP-ribose) polymerase inhibitors exhibit strong activity for treating the DNA damage repair defect in patients with prostate carcinoma (PCa). Although conventional DNA-damaging agents can theoretically lead to synthetic antitumoral effects, no report has clearly mentioned the clinical use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Koguchi, Dai, Tabata, Ken-ichi, Tsumura, Hideyasu, Mori, Kohei, Koh, Hideshige, Iwamura, Masatsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175266/
https://www.ncbi.nlm.nih.gov/pubmed/34123730
http://dx.doi.org/10.1016/j.eucr.2021.101712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175266/
https://www.ncbi.nlm.nih.gov/pubmed/34123730
http://dx.doi.org/10.1016/j.eucr.2021.101712

Ejemplares similares